Methods for determining key components in a mathematical model for tumor–immune dynamics in multiple myeloma-Reference-Cited by-同舟云学术

Methods for determining key components in a mathematical model for tumor–immune dynamics in multiple myeloma

Published:2018-12 Issue: Volume:458 Page:31-46
ISSN:0022-5193
Container-title:Journal of Theoretical Biology
language:en
Short-container-title:Journal of Theoretical Biology

Author:

Gallaher Jill,Larripa Kamila,Renardy Marissa,Shtylla Blerta,Tania Nessy,White Diana,Wood Karen,Zhu Li,Passey Chaitali,Robbins Michael,Bezman Natalie,Shelat Suresh,Jay Cho Hearn,Moore Helen^ORCID

Funder

Bristol-Myers Squibb

Publisher

Elsevier BV

Subject

Applied Mathematics,General Agricultural and Biological Sciences,General Immunology and Microbiology,General Biochemistry, Genetics and Molecular Biology,Modeling and Simulation,General Medicine,Statistics and Probability

Reference87 articles.

1. Cellular and Molecular Immunology;Abbas,2015

2. A mathematical model of tumor-immune evasion and siRNA treatment;Arciero;Discrete Continuous Dyn. Syst. Ser. B,2004

3. An iterative identification procedure for dynamic modeling of biochemical networks;Balsa-Canto;BMC Syst. Biol.,2010

4. Macrophage T lymphocyte interactions in the anti-tumor immune response: a mathematical model;de Boer;J. Immunol.,1985

5. Different dynamics of CD4+ and CD8+ T cell responses during and after acute lymphocytic choriomeningitis virus infection;de Boer;J. Immunol.,2003

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Role of Effector CD$$8^{+}$$ T Cells Against Circulating Tumor Cells Cloaked with Platelets: Insights from a Mathematical Model;Bulletin of Mathematical Biology;2024-06-17

2. The bone ecosystem facilitates multiple myeloma relapse and the evolution of heterogeneous drug resistant disease;Nature Communications;2024-03-19

3. Myeloma Comes as a Staple: A Case Report of the Roy Adaptation Model;Uludağ Üniversitesi Tıp Fakültesi Dergisi;2023-09-08

4. Longitudinal efficacy and safety modeling and simulation framework to aid dose selection of belantamab mafodotin for patients with multiple myeloma;CPT: Pharmacometrics & Systems Pharmacology;2023-08-02

5. Determining optimal combination regimens for patients with multiple myeloma;European Journal of Pharmaceutical Sciences;2023-08